SMMT logo

Summit Therapeutics Inc. (SMMT) EBIT

Annual EBIT:

-$211.30M-$121.57M(-135.47%)
December 31, 2024

Summary

  • As of today, SMMT annual earnings before interest & taxes is -$211.30 million, with the most recent change of -$121.57 million (-135.47%) on December 31, 2024.
  • During the last 3 years, SMMT annual EBIT has fallen by -$104.15 million (-97.20%).

Performance

SMMT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

Quarterly EBIT:

-$234.21M+$334.23M(+58.80%)
September 30, 2025

Summary

  • As of today, SMMT quarterly earnings before interest & taxes is -$234.21 million, with the most recent change of +$334.23 million (+58.80%) on September 30, 2025.
  • Over the past year, SMMT quarterly EBIT has dropped by -$176.10 million (-303.02%).
  • SMMT quarterly EBIT is now -782.90% below its all-time high of $34.30 million, reached on July 31, 2018.

Performance

SMMT Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

TTM EBIT:

-$935.30M-$176.10M(-23.20%)
September 30, 2025

Summary

  • As of today, SMMT TTM earnings before interest & taxes is -$935.30 million, with the most recent change of -$176.10 million (-23.20%) on September 30, 2025.
  • Over the past year, SMMT TTM EBIT has dropped by -$753.41 million (-414.23%).
  • SMMT TTM EBIT is now -30939.46% below its all-time high of $3.03 million, reached on April 1, 2019.

Performance

SMMT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

SMMT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-135.5%-303.0%-414.2%
3Y3 Years-97.2%-945.5%-877.2%
5Y5 Years-284.9%-1048.6%-1686.0%

SMMT EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-166.4%at low-1706.6%+58.8%-1310.5%at low
5Y5-Year-284.9%at low-1706.6%+58.8%-1686.0%at low
All-TimeAll-Time>-9999.0%at low-782.9%+58.8%>-9999.0%at low

SMMT EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$234.21M(+58.8%)
-$935.30M(-23.2%)
Jun 2025
-
-$568.44M(-750.3%)
-$759.20M(-222.3%)
Mar 2025
-
-$66.85M(-1.6%)
-$235.53M(-11.5%)
Dec 2024
-$211.30M(-135.5%)
-$65.80M(-13.2%)
-$211.28M(-16.2%)
Sep 2024
-
-$58.11M(-29.8%)
-$181.88M(-25.8%)
Jun 2024
-
-$44.77M(-5.1%)
-$144.53M(-25.1%)
Mar 2024
-
-$42.60M(-17.0%)
-$115.53M(-28.7%)
Dec 2023
-$89.74M(-13.2%)
-$36.40M(-75.4%)
-$89.75M(-35.3%)
Sep 2023
-
-$20.76M(-31.6%)
-$66.31M(+2.4%)
Jun 2023
-
-$15.77M(+6.3%)
-$67.96M(-0.1%)
Mar 2023
-
-$16.82M(-29.8%)
-$67.89M(+13.0%)
Dec 2022
-$79.30M(+26.0%)
-$12.96M(+42.1%)
-$78.04M(+18.5%)
Sep 2022
-
-$22.40M(-42.6%)
-$95.71M(+1.9%)
Jun 2022
-
-$15.71M(+41.8%)
-$97.60M(+12.7%)
Mar 2022
-
-$26.96M(+12.0%)
-$111.75M(-4.3%)
Dec 2021
-$107.15M(-49.6%)
-$30.64M(-26.1%)
-$107.15M(-15.9%)
Sep 2021
-
-$24.30M(+18.6%)
-$92.44M(-4.4%)
Jun 2021
-
-$29.85M(-33.4%)
-$88.53M(-13.7%)
Mar 2021
-
-$22.37M(-40.5%)
-$77.86M(-14.0%)
Dec 2020
-$71.65M(-30.5%)
-
-
Dec 2020
-
-$15.92M(+21.9%)
-$68.29M(-30.4%)
Sep 2020
-
-$20.39M(-6.3%)
-$52.37M(-63.8%)
Jun 2020
-
-$19.18M(-49.8%)
-$31.98M(-149.8%)
Mar 2020
-
-$12.80M(>-9900.0%)
-$12.80M(>-9900.0%)
Jan 2020
-
$0.00(0.0%)
$0.00(+100.0%)
Dec 2019
-$54.90M(>-9900.0%)
-
-
Oct 2019
-
$0.00(0.0%)
-$15.46M(+50.5%)
Jul 2019
-
$0.00(0.0%)
-$31.26M(-1130.8%)
Apr 2019
-
$0.00(+100.0%)
$3.03M(+127.5%)
Jan 2019
$0.00(+100.0%)
-
-
Jan 2019
-
-$15.46M(+2.1%)
-$11.03M(+3.3%)
Oct 2018
-
-$15.80M(-146.1%)
-$11.41M(-152.9%)
Jul 2018
-
$34.30M(+343.8%)
-$4.51M(+89.8%)
Apr 2018
-
-$14.06M(+11.2%)
-$44.42M(-18.4%)
Jan 2018
-$34.56M(-6.3%)
-
-
Jan 2018
-
-$15.84M(-77.9%)
-$37.52M(-28.3%)
Oct 2017
-
-$8.90M(-58.7%)
-$29.25M(-7.8%)
Jul 2017
-
-$5.61M(+21.7%)
-$27.14M(+14.4%)
Apr 2017
-
-$7.17M(+5.3%)
-$31.71M(+5.2%)
Jan 2017
-$32.50M(+3.1%)
-
-
Jan 2017
-
-$7.56M(-11.3%)
-$33.46M(+4.5%)
Oct 2016
-
-$6.79M(+33.3%)
-$35.02M(+4.2%)
Jul 2016
-
-$10.19M(-14.4%)
-$36.55M(-9.0%)
Apr 2016
-
-$8.91M(+2.4%)
-$33.55M(-9.3%)
Jan 2016
-$33.53M(-48.8%)
-
-
Jan 2016
-
-$9.13M(-9.6%)
-$30.68M(-12.1%)
Oct 2015
-
-$8.33M(-15.9%)
-$27.37M(-43.7%)
Jul 2015
-
-$7.18M(-18.9%)
-$19.04M(-60.6%)
Apr 2015
-
-$6.04M(-3.9%)
-$11.86M(-103.9%)
Jan 2015
-$22.53M(-100.8%)
-
-
Jan 2015
-
-$5.82M(>-9900.0%)
-$5.82M(>-9900.0%)
Oct 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2014
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2014
-$11.22M
-
-
Jan 2014
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Oct 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2013
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2013
-$5.77M(-21.0%)
-
-
Jan 2013
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2012
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2012
-$4.77M(+17.8%)
-
-
Jan 2012
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2011
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2011
-$5.81M(+38.1%)
-
-
Jan 2011
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2010
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2010
-$9.38M(+61.1%)
-
-
Jan 2010
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2009
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2009
-$24.10M(+2.8%)
-
-
Jan 2009
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2008
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2008
-$24.81M(-199.5%)
-
-
Jan 2008
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2007
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2007
-$8.28M(-154.5%)
-
-
Jan 2007
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2006
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2006
-$3.25M(-521.3%)
-
-
Jan 2006
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2005
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2005
-$523.80K(-324.8%)
-
-
Jan 2005
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2004
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2004
-$123.30K(>-9900.0%)
-
-
Jan 2004
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2003
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2003
$0.00
$0.00(0.0%)
$0.00(0.0%)
Oct 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2002
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2002
-
$0.00
$0.00

FAQ

  • What is Summit Therapeutics Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual EBIT year-on-year change?
  • What is Summit Therapeutics Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly EBIT year-on-year change?
  • What is Summit Therapeutics Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. TTM EBIT year-on-year change?

What is Summit Therapeutics Inc. annual earnings before interest & taxes?

The current annual EBIT of SMMT is -$211.30M

What is the all-time high annual EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual earnings before interest & taxes is $0.00

What is Summit Therapeutics Inc. annual EBIT year-on-year change?

Over the past year, SMMT annual earnings before interest & taxes has changed by -$121.57M (-135.47%)

What is Summit Therapeutics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of SMMT is -$234.21M

What is the all-time high quarterly EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly earnings before interest & taxes is $34.30M

What is Summit Therapeutics Inc. quarterly EBIT year-on-year change?

Over the past year, SMMT quarterly earnings before interest & taxes has changed by -$176.10M (-303.02%)

What is Summit Therapeutics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of SMMT is -$935.30M

What is the all-time high TTM EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high TTM earnings before interest & taxes is $3.03M

What is Summit Therapeutics Inc. TTM EBIT year-on-year change?

Over the past year, SMMT TTM earnings before interest & taxes has changed by -$753.41M (-414.23%)
On this page